Victory Capital Management
TNGX icon

Victory Capital Management’s Tango Therapeutics TNGX Stock Holding History

Victory Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.53M Buy
176,748
+123,947
+235% +$3.06M ﹤0.01% 1335
2026
Q1 		$1.1M Buy
52,801
+42,595
+417% +$593K ﹤0.01% 1798
2025
Q4 		$90.4K Buy
+10,206
New +$87.9K ﹤0.01% 2278
2024
Q2 		– Sell
-58,180
Closed -$462K – 2533
2024
Q1 		$462K Sell
58,180
-14,460
-20% -$155K ﹤0.01% 2011
2023
Q4 		$719K Buy
+72,640
New +$631K ﹤0.01% 1859
2021
Q4 		– Sell
-11,022
Closed -$143K – 2846
2021
Q3 		$143K Buy
+11,022
New +$132K ﹤0.01% 2582

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Victory Capital Management's TNGX Position: Q2 2026 in Review

Victory Capital Management increased its Tango Therapeutics (TNGX) stake by 235% in Q2 2026, buying an estimated $3.06M and bringing the position to 176,748 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Victory Capital Management first reported a position in TNGX in Q3 2021 and has held it in 6 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Victory Capital Management held 176,748 shares of Tango Therapeutics worth $5.53M as of Q2 2026.
  • Victory Capital Management bought 123,947 Tango Therapeutics shares in Q2 2026, an estimated $3.06M.
  • Tango Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1335 holding.
  • Victory Capital Management first reported a position in Tango Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.